TY - JOUR
T1 - Cushing's disease and idiopathic intracranial hypertension
T2 - Case report and review of underlying pathophysiological mechanisms
AU - Zada, Gabriel
AU - Tirosh, Amir
AU - Kaiser, Ursula B.
AU - Laws, Edward R.
AU - Woodmansee, Whitney W.
PY - 2010/11
Y1 - 2010/11
N2 - Context: Several studies have reported an association between idiopathic intracranial hypertension (IIH) and deficits of the hypothalamic-pituitary- adrenal (HPA) axis. Case Illustration: A 33-yr-old woman with Cushing's disease underwent successful surgical resection of a pituitaryadenomaanddeveloped IIH 11 months later after inadvertent withdrawal of oral glucocorticoids. Methods: A review of the literature was conducted to identify previous studies pertaining to IIH in association with neuroendocrine disease, focusing on reports related to HPA axis dysfunction. Results: A number of patients developing IIH due to a relative deficiency in glucocorticoids, after surgical or medical management for Cushing's disease, withdrawal from glucocorticoid replacement, or as an initial presentation of Addison's disease, have been reported. Hypotheses regarding the underlying pathophysiology of IIH in this context and, in particular, the role of cortisol and its relationship to other neuroendocrine and inflammatory mediators that may regulate the homeostasis of cerebrospinal fluid production and absorption are reviewed. Conclusion: In a subset of patients, dysfunction of the HPA axis appears to play a role in the development of IIH. Hormonal control of cerebrospinal fluid production and absorption may be regulated by inflammatory mediators and the enzyme 11β-hydroxysteroid dehydrogenase type 1. Further study of neuroendocrine markers in the serum and cerebrospinal fluid may be an avenue for further research in IIH.
AB - Context: Several studies have reported an association between idiopathic intracranial hypertension (IIH) and deficits of the hypothalamic-pituitary- adrenal (HPA) axis. Case Illustration: A 33-yr-old woman with Cushing's disease underwent successful surgical resection of a pituitaryadenomaanddeveloped IIH 11 months later after inadvertent withdrawal of oral glucocorticoids. Methods: A review of the literature was conducted to identify previous studies pertaining to IIH in association with neuroendocrine disease, focusing on reports related to HPA axis dysfunction. Results: A number of patients developing IIH due to a relative deficiency in glucocorticoids, after surgical or medical management for Cushing's disease, withdrawal from glucocorticoid replacement, or as an initial presentation of Addison's disease, have been reported. Hypotheses regarding the underlying pathophysiology of IIH in this context and, in particular, the role of cortisol and its relationship to other neuroendocrine and inflammatory mediators that may regulate the homeostasis of cerebrospinal fluid production and absorption are reviewed. Conclusion: In a subset of patients, dysfunction of the HPA axis appears to play a role in the development of IIH. Hormonal control of cerebrospinal fluid production and absorption may be regulated by inflammatory mediators and the enzyme 11β-hydroxysteroid dehydrogenase type 1. Further study of neuroendocrine markers in the serum and cerebrospinal fluid may be an avenue for further research in IIH.
UR - https://www.scopus.com/pages/publications/78049506724
U2 - 10.1210/jc.2010-0896
DO - 10.1210/jc.2010-0896
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:78049506724
SN - 0021-972X
VL - 95
SP - 4850
EP - 4854
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 11
ER -